Fusion Antibodies (FAB) Insider Trading & Ownership GBX 6.20 -0.05 (-0.80%) As of 12:42 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Fusion Antibodies (LON:FAB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.39%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)£14,293.87Number OfInsiders Selling(Last 12 Months)0 Get FAB Insider Trade Alerts Want to know when executives and insiders are buying or selling Fusion Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FAB Insider Buying and Selling by Quarter Remove Ads Fusion Antibodies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/16/2024Adrian KinkaidInsiderBuy83,728GBX 4£3,349.129/9/2024Richard John BuickInsiderBuy94,825GBX 3£2,844.759/4/2024Adrian KinkaidInsiderBuy120,000GBX 3£3,6007/22/2024Simon Gordon DouglasInsiderBuy150,000GBX 3£4,500 (Data available from 1/1/2013 forward) FAB Insider Trading Activity - Frequently Asked Questions Who is on Fusion Antibodies's Insider Roster? The list of insiders at Fusion Antibodies includes Adrian Kinkaid, Richard John Buick, Simon Gordon Douglas, and Sonya Maria Ferguson. Learn more on insiders at FAB. What percentage of Fusion Antibodies stock is owned by insiders? 11.39% of Fusion Antibodies stock is owned by insiders. Learn more on FAB's insider holdings. Which Fusion Antibodies insiders have been buying company stock? The following insiders have purchased FAB shares in the last 24 months: Adrian Kinkaid (£6,949.12), Richard John Buick (£7,657.25), and Simon Gordon Douglas (£9,528.25). How much insider buying is happening at Fusion Antibodies? Insiders have purchased a total of 617,868 FAB shares in the last 24 months for a total of £24,134.62 bought. Fusion Antibodies Key ExecutivesDr. Adrian Robert Kinkaid Ph.D. (Age 57)CEO & Director Compensation: $183.49kDr. Richard John Buick Ph.D. (Age 48)Chief Scientific Officer & Director Compensation: $127kProf. Jim JohnstonFounderMr. Stephen Barry Smyth (Age 50)Company Secretary, Interim CFO & Director Ms. Nicola HamiltonOperations ManagerDr. Paul Gerard Kerr (Age 51)Consultant Compensation: $180.38k More Insider Trading Tools from MarketBeat Related Companies POLB Insider Transactions SAR Insider Transactions OBD Insider Transactions IXI Insider Transactions DEST Insider Transactions ROQ Insider Transactions ONC Insider Transactions OCTP Insider Transactions GNS Insider Transactions ONT Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (LON:FAB) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Antibodies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.